[18F](2S,4R)-4-Fluoroglutamine

N/A

Report date: 2025/11/27 15:47:49
NME

Base Information

Drug Name[18F](2S,4R)-4-Fluoroglutamine
Drug Alias Name[18F]4-L-Fluoroglutamine[18F] 4-L-fluoroglutamine (2S, 4R)[18F]4F-Gln
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsPulmonary Arterial HypertensionNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer CenterBayer AGUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial HypertensionNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A